FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Lucia Viganò

Research Profile

Concepts & Ideas

Procedures

Antineoplastic Combined Chemotherapy Protocols

Disorders

Chemicals & Drugs

Physiology

Drug Interactions

Anatomy

Co-author Network

Publications

TOP 3
Antonella Perotti; Alberta Locatelli; Cristiana Sessa; D Hess; Lucia Viganò; Giuseppe Capri; Michela Maur; Thomas Cerny; Sara Cresta; Federico Rojo; Joan Albanell; Silvia Marsoni; Irene Corradino; Lori Berk; Victor M Rivera; Frank Haluska; Luca Gianni
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine.
Cristiana Sessa; D Tosi; Lucia Viganò; J Albanell; D Hess; Michela Maur; Sara Cresta; Alberta Locatelli; R Angst; F Rojo; N Coceani; V M Rivera; L Berk; F Haluska; Luca Gianni
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.
Roberta Frapolli; Massimo Zucchetti; Cristiana Sessa; Silvia Marsoni; Lucia Viganò; Alberta Locatelli; Eliana Rulli; Anna Compagnoni; Ezia Bello; Claudio Pisano; Paolo Carminati; Maurizio D'Incalci
Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levels.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Lucia Viganò (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2010: Antonella Perotti; Alberta Locatelli; Cristiana Sessa; D Hess; Lucia Viganò; Giuseppe Capri; Michela Maur; Thomas Cerny; Sara Cresta; Federico Rojo; Joan Albanell; Silvia Marsoni; Irene Corradino; Lori Berk; Victor M Rivera; Frank Haluska; Luca Gianni
Phase IB study of the mTOR inhibitor ridaforolimus with capecitabine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(30):4554-61.
2010: Cristiana Sessa; D Tosi; Lucia Viganò; J Albanell; D Hess; Michela Maur; Sara Cresta; Alberta Locatelli; R Angst; F Rojo; N Coceani; V M Rivera; L Berk; F Haluska; Luca Gianni
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxel.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2010;21(6):1315-22.
2010: Roberta Frapolli; Massimo Zucchetti; Cristiana Sessa; Silvia Marsoni; Lucia Viganò; Alberta Locatelli; Eliana Rulli; Anna Compagnoni; Ezia Bello; Claudio Pisano; Paolo Carminati; Maurizio D'Incalci
Clinical pharmacokinetics of the new oral camptothecin gimatecan: the inter-patient variability is related to alpha1-acid glycoprotein plasma levels.
European journal of cancer (Oxford, England : 1990) 2010;46(3):505-16.
2006: Cristiana Sessa; Lucia Viganò; Giacomo Grasselli; Josè Trigo; Irene Marimon; Anna Lladò; Alberta Locatelli; Nicoletta Ielmini; Silvia Marsoni; Luca Gianni
Phase I clinical and pharmacological evaluation of the multi-tyrosine kinase inhibitor SU006668 by chronic oral dosing.
European journal of cancer (Oxford, England : 1990) 2006;42(2):171-8.
2004: Cristiana Sessa; Antonella Perotti; Emanuela Salvatorelli; Giorgio Minotti; Lucia Viganò; Anna Lladò; Giuseppe Capri; Alberta Locatelli; S Colombini; Fedro Alessandro Peccatori; Maurizio Voi; Silvia Marsoni; Luca Gianni
Phase IB and pharmacological study of the novel taxane BMS-184476 in combination with doxorubicin.
European journal of cancer (Oxford, England : 1990) 2004;40(4):563-70.
2003: Luca Gianni; Giacomo Grasselli; Sara Cresta; Alberta Locatelli; Lucia Viganò; Giorgio Minotti
Anthracyclines.
Cancer chemotherapy and biological response modifiers 2003;21():29-40.
2002: Luca Gianni; Giacomo Grasselli; Sara Cresta; Alberta Locatelli; Lucia Viganò; Giorgio Minotti
Anthracyclines.
Cancer chemotherapy and biological response modifiers 2002;20():59-69.
2001: Giacomo Grasselli; Lucia Viganò; Giuseppe Capri; Alberta Locatelli; E Tarenzi; C Spreafico; A Bertuzzi; A Giani; C Materazzo; Sara Cresta; Antonella Perotti; Pinuccia Valagussa; Luca Gianni
Clinical and pharmacologic study of the epirubicin and paclitaxel combination in women with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2222-31.
2000: Cristiana Sessa; Giuseppe Capri; Luca Gianni; Fedro Alessandro Peccatori; Giacomo Grasselli; J Bauer; Massimo Zucchetti; Lucia Viganò; A Gatti; C Minoia; P Liati; S Van den Bosch; A Bernareggi; Gabriella Camboni; Silvia Marsoni
Clinical and pharmacological phase I study with accelerated titration design of a daily times five schedule of BBR3464, a novel cationic triplatinum complex.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(8):977-83.
1998: Philip N Hawkins; C Aprile; Giuseppe Capri; Lucia Viganò; Elisabetta Munzone; Luca Gianni; Mark B Pepys; G Merlini
Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis.
European journal of nuclear medicine 1998;25(7):701-8.
1997: Luca Gianni; Lucia Viganò; Alberta Locatelli; Giuseppe Capri; A Giani; E Tarenzi; Gianni Bonadonna
Human pharmacokinetic characterization and in vitro study of the interaction between doxorubicin and paclitaxel in patients with breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1906-15.
1990: Luca Gianni; Lucia Viganò; A Surbone; D Ballinari; P Casali; C Tarella; J M Collins; Gianni Bonadonna
Pharmacology and clinical toxicity of 4'-iodo-4'-deoxydoxorubicin: an example of successful application of pharmacokinetics to dose escalation in phase I trials.
Journal of the National Cancer Institute 1990;82(6):469-77.
1988: Luca Gianni; Lucia Viganò; C Lanzi; M Niggeler; V Malatesta
Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines.
Journal of the National Cancer Institute 1988;80(14):1104-11.